Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 4 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             6.94                8.65             39.60    
                 (-19.8 pct)         (-2.2 pct)       (+14.6 pct) 
  Operating        693 mln              2.25              6.50    
                 (-69.2 pct)         (+45.8 pct)      (+3.6 pct)  
  Recurring        745 mln              2.20              6.60    
                 (-66.1 pct)         (+41.1 pct)      (+4.0 pct)  
  Net              404 mln              1.59              4.00    
                 (-74.6 pct)         (+54.2 pct)      (+4.7 pct)  
  EPS             3.36 yen            13.22 yen        33.22 yen  
  Ann Div                             8.00 yen         8.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             8.00 yen         8.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news